A Combination of Vemurafenib, Cytarabine and 2-chlorodeoxyadenosine in Children With LCH and BRAF V600E Mutation
Clinical trial NCT03585686 · UNKNOWN
Trial details
- NCT number
- NCT03585686
- Sponsor
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-26
- Primary completion
- 2023-04-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.